Jeremy Agresti, PhDFounder and CTO at Triplebar
Dr. Agresti has spent his career developing tools to drastically change the pace of biology with massive-throughput measurements using microfluidics. His seminal contributions as pioneer of miniaturizing biology with microfluidics have resulted in a large number of publications and patents, which have been cited more than 9,000 times, and form the foundation of several companies in the space. His work has allowed Amyris to bring their biofuels and chemicals to market faster, and for companies like Bio-Rad, Illumina and 10x Genomics to bring new single-cell genomics tools and clinical diagnostic tests to market. Jeremy is a co-founder and advisor to Slingshot Biosciences and CTO and Founder of Triplebar, where he leads a team of scientists and engineers to leverage the power of evolution to bring new biology-produced products to the world and build a sustainable future for the planet.